Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishnendu Nandi

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Indian Journal of Ophthalmology|March 25, 2022
Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes - A multicenter retrospective studyDebdulal Chakraborty, Aniruddha Maiti, Sabyasachi Sengupta, et al.
Journal of the Indian Medical Association|October 9, 2008
Ophthalmic manifestations in people living with HIV attending a tertiary care centre of Eastern IndiaPradyot Narayan Biswas, Bibhuti Saha, Sambuddha Ghosh, et al.
Indian Journal of Ophthalmology|April 16, 2024
Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in IndiaDebdulal Chakraborty, Soumen Mondal, Sabyasachi Sengupta, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 15, 2021
Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE StudyDebdulal Chakraborty, Aniruddha Maiti, Jay U Sheth, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 30, 2022
Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study - Fifty-Two-Week OutcomesDebdulal Chakraborty, Aniruddha Maiti, Jay U Sheth, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 16, 2025
Biosimilar Versus Innovator Ranibizumab in Myopic CNVM: Comparative Real-World Outcomes- The BRIM StudyDebdulal Chakraborty, Tushar Kanti Sinha, Sourav Sinha, et al.
Investigative Ophthalmology & Visual Science|June 21, 2008
Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachmentKarunakaran Coral, Narayanasamy Angayarkanni, Jagadeesan Madhavan, et al.
Indian Journal of Ophthalmology|July 26, 2020
Detection of retinal laser injury using confocal scanning laser imagingRupak Roy, Kumar Saurabh, Rupak K Biswas, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 2, 2024
Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational StudyDebdulal Chakraborty, Tushar Kanti Sinha, Aniruddha Maiti, et al.
Clinical & Experimental Optometry|December 6, 2019
The red lens: a case of florid lens neovascularisationRupak Roy, Kumar Saurabh, Prashant Srivastava, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Indian Journal of Ophthalmology|March 25, 2022
Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes - A multicenter retrospective studyDebdulal Chakraborty, Aniruddha Maiti, Sabyasachi Sengupta, et al.
Journal of the Indian Medical Association|October 9, 2008
Ophthalmic manifestations in people living with HIV attending a tertiary care centre of Eastern IndiaPradyot Narayan Biswas, Bibhuti Saha, Sambuddha Ghosh, et al.
Indian Journal of Ophthalmology|April 16, 2024
Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in IndiaDebdulal Chakraborty, Soumen Mondal, Sabyasachi Sengupta, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 15, 2021
Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE StudyDebdulal Chakraborty, Aniruddha Maiti, Jay U Sheth, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 30, 2022
Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study - Fifty-Two-Week OutcomesDebdulal Chakraborty, Aniruddha Maiti, Jay U Sheth, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 16, 2025
Biosimilar Versus Innovator Ranibizumab in Myopic CNVM: Comparative Real-World Outcomes- The BRIM StudyDebdulal Chakraborty, Tushar Kanti Sinha, Sourav Sinha, et al.
Investigative Ophthalmology & Visual Science|June 21, 2008
Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachmentKarunakaran Coral, Narayanasamy Angayarkanni, Jagadeesan Madhavan, et al.
Indian Journal of Ophthalmology|July 26, 2020
Detection of retinal laser injury using confocal scanning laser imagingRupak Roy, Kumar Saurabh, Rupak K Biswas, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 2, 2024
Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational StudyDebdulal Chakraborty, Tushar Kanti Sinha, Aniruddha Maiti, et al.
Clinical & Experimental Optometry|December 6, 2019
The red lens: a case of florid lens neovascularisationRupak Roy, Kumar Saurabh, Prashant Srivastava, et al.
Pageof 3